首页 > 最新文献

Ginekologia polska最新文献

英文 中文
Is it possible to predict severe postpartum hemorrhage and the need for massive transfusion in placenta previa cases? 能否预测前置胎盘病例中的严重产后出血和大量输血需求?
Pub Date : 2025-01-01 Epub Date: 2025-03-12 DOI: 10.5603/gpl.103049
Emre Köle, Bertan Akar, Emek Doğer, Merve Çakır Köle, Yonca Anık, Eray Çalışkan

Objectives: The aim was to construct a reliable working model for patients with placenta previa (PP) that aids in the prediction of postpartum bleeding potential with data from antenatal imaging studies using both ultrasound (US) and magnetic resonance imaging (MRI).

Material and methods: Forty-three patients with PP were evaluated initially with the US and then by 3-Tesla MRI. The Placenta Accreata Index (PAI) was used during the US evaluation in order to define the risks. Uterine bulging, heterogeneous signal, dark placental bands, focal interruption of myometrium and tenting of bladder wall were regarded as predictive criteria in MRI evaluation. The correlation between the findings from US and MRI studies and subsequent haemorrhage, < 1000 mL, > 1000 mL and severe haemorrhage ( > 2000 mL) and massive transfusion [ > 5 units of red blood cells (RBC)] were used to build this predictive model. The findings from the imaging studies were also confirmed histopathologically.

Results: In the multivariate analysis of data from patients stratified by bleed size either < 1000 mL or > 1000 mL, none of the MRI and ultrasound findings were found to be predictive. The multivariate analysis was done using the second stratification cut-point of 2000 mL, in patients bleeding > 2000 mL PAI values [OR: 2.3 (1.4-3.8)] and overall MRI reported placenta accreata spectrum [OR: 4.9 (1.8-12.9)] were found to be predictive. While MRI findings were not discriminative between transfusion groups, grade 3 loculation on US examination was found to be predictive for the need of transfusion of > 5 units [OR: 67.5 (8.2-549.4)]. There were no cases needing hysterectomy.

Conclusions: Ultrasound and MRI findings in cases of PP can be helpful in predicting postpartum bleeding.

目的:目的是为前置胎盘(PP)患者建立一个可靠的工作模型,利用超声(US)和磁共振成像(MRI)的产前影像学研究数据,帮助预测产后出血的可能性。材料与方法:对43例PP患者进行超声心动图和3-特斯拉MRI评估。在美国评估中使用胎盘增生指数(PAI)来确定风险。子宫膨出、信号异质、胎盘带暗色、肌层局灶性中断、膀胱壁呈帐篷状是MRI评价的预测标准。US和MRI检查结果与随后出血、< 1000ml、>000ml和严重出血(> 2000ml)和大量输血[> 5单位红细胞(RBC)]之间的相关性被用来建立该预测模型。影像学检查的结果也得到了组织病理学的证实。结果:在多因素分析中,根据出血大小< 1000ml或> 1000ml分层的患者数据,MRI和超声结果均未发现预测性。多因素分析采用2000 mL的第二分层切点,在出血患者中,发现2000 mL PAI值[OR: 2.3(1.4-3.8)]和总体MRI报告的胎盘增生谱[OR: 4.9(1.8-12.9)]具有预测性。虽然MRI结果在输血组之间没有区别,但发现US检查的3级定位可预测bbbb5单位的输血需求[OR: 67.5(8.2-549.4)]。没有病例需要子宫切除术。结论:PP病例的超声和MRI检查有助于预测产后出血。
{"title":"Is it possible to predict severe postpartum hemorrhage and the need for massive transfusion in placenta previa cases?","authors":"Emre Köle, Bertan Akar, Emek Doğer, Merve Çakır Köle, Yonca Anık, Eray Çalışkan","doi":"10.5603/gpl.103049","DOIUrl":"10.5603/gpl.103049","url":null,"abstract":"<p><strong>Objectives: </strong>The aim was to construct a reliable working model for patients with placenta previa (PP) that aids in the prediction of postpartum bleeding potential with data from antenatal imaging studies using both ultrasound (US) and magnetic resonance imaging (MRI).</p><p><strong>Material and methods: </strong>Forty-three patients with PP were evaluated initially with the US and then by 3-Tesla MRI. The Placenta Accreata Index (PAI) was used during the US evaluation in order to define the risks. Uterine bulging, heterogeneous signal, dark placental bands, focal interruption of myometrium and tenting of bladder wall were regarded as predictive criteria in MRI evaluation. The correlation between the findings from US and MRI studies and subsequent haemorrhage, < 1000 mL, > 1000 mL and severe haemorrhage ( > 2000 mL) and massive transfusion [ > 5 units of red blood cells (RBC)] were used to build this predictive model. The findings from the imaging studies were also confirmed histopathologically.</p><p><strong>Results: </strong>In the multivariate analysis of data from patients stratified by bleed size either < 1000 mL or > 1000 mL, none of the MRI and ultrasound findings were found to be predictive. The multivariate analysis was done using the second stratification cut-point of 2000 mL, in patients bleeding > 2000 mL PAI values [OR: 2.3 (1.4-3.8)] and overall MRI reported placenta accreata spectrum [OR: 4.9 (1.8-12.9)] were found to be predictive. While MRI findings were not discriminative between transfusion groups, grade 3 loculation on US examination was found to be predictive for the need of transfusion of > 5 units [OR: 67.5 (8.2-549.4)]. There were no cases needing hysterectomy.</p><p><strong>Conclusions: </strong>Ultrasound and MRI findings in cases of PP can be helpful in predicting postpartum bleeding.</p>","PeriodicalId":94021,"journal":{"name":"Ginekologia polska","volume":" ","pages":"308-313"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143607501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations vulvar lichen sclerosus with autoimmune thyroid diseases. 外阴硬皮病与自身免疫性甲状腺疾病的关系
Pub Date : 2025-01-01 Epub Date: 2024-10-29 DOI: 10.5603/gpl.103145
Maja J Zieba-Domalik, Dominika Orszulak, Kacper Nizinski, Katarzyna Wilk, Marta Janik, Rafal Stojko, Agnieszka Drosdzol-Cop

Objectives: Vulvar lichen sclerosus (VLS) is defined as a chronic inflammatory skin disease that most often involves lesions on the mucous membranes of the vulva with a tendency to progress to the anal skin. The etiopathogenesis of VLS remains unknown and is likely multifactorial. Data emphasize the role of immunological factors - more than 25% of VLS cases coexist with autoimmune diseases. The purpose of the present study was to determine the correlation of the prevalence of anti-thyroid antibodies - IgG class antibodies against thyroid peroxidase and IgG class antibodies against thyroglobulin in women with vulvar lichen sclerosus, and the appropriateness of screening tests for autoimmune thyroid diseases in women with vulvar lichen sclerosus.

Material and methods: Fifty women with vulvar lichen sclerosus were enrolled in the study. The control group consisted of 41 healthy women. A detailed medical history was taken with all patients, followed by laboratory determinations - anti-thyroid antibodies - IgG class antibodies against thyroid peroxidase and IgG class antibodies against thyroglobulin.

Results: Antibodies to thyroid peroxidase were present in 12% of the study group with vulvar lichen sclerosus and 4.88% of the control group, and this difference was not statistically significant (p = 0.41). Anti-thyroglobulin antibodies were detected in 4% of the patients with vulvar lichen sclerosus and 4.88% of the control group, and this difference was not statistically significant either (p = 0.76).

Conclusions: The study did not confirm the association of VLS with autoimmune thyroid diseases. Undoubtedly, based on the data available in the literature, further studies are needed to determine the mechanisms behind the association between vulvar lichen sclerosus and autoimmune thyroid diseases.

目的:外阴硬化性苔藓(VLS)是一种慢性炎症性皮肤病,多发于外阴粘膜,并有向肛门皮肤发展的趋势。VLS 的发病机制尚不清楚,可能是多因素引起的。有数据强调了免疫因素的作用--超过 25% 的 VLS 病例与自身免疫性疾病同时存在。本研究的目的是确定外阴硬化性苔藓妇女中抗甲状腺抗体(抗甲状腺过氧化物酶IgG类抗体和抗甲状腺球蛋白IgG类抗体)患病率的相关性,以及外阴硬化性苔藓妇女自身免疫性甲状腺疾病筛查试验的适宜性:研究对象为50名患有外阴硬化性苔藓的妇女。对照组由 41 名健康妇女组成。向所有患者详细询问病史,然后进行实验室测定--抗甲状腺抗体--甲状腺过氧化物酶 IgG 类抗体和甲状腺球蛋白 IgG 类抗体:甲状腺过氧化物酶抗体在外阴硬皮病研究组中占 12%,在对照组中占 4.88%,差异无统计学意义(P = 0.41)。4%的外阴硬化性苔藓患者和4.88%的对照组患者检测到抗甲状腺球蛋白抗体,差异也无统计学意义(P = 0.76):该研究并未证实外阴硬化症与自身免疫性甲状腺疾病有关。毫无疑问,根据现有的文献数据,还需要进一步的研究来确定外阴苔藓硬化症与自身免疫性甲状腺疾病之间的关联机制。
{"title":"Associations vulvar lichen sclerosus with autoimmune thyroid diseases.","authors":"Maja J Zieba-Domalik, Dominika Orszulak, Kacper Nizinski, Katarzyna Wilk, Marta Janik, Rafal Stojko, Agnieszka Drosdzol-Cop","doi":"10.5603/gpl.103145","DOIUrl":"10.5603/gpl.103145","url":null,"abstract":"<p><strong>Objectives: </strong>Vulvar lichen sclerosus (VLS) is defined as a chronic inflammatory skin disease that most often involves lesions on the mucous membranes of the vulva with a tendency to progress to the anal skin. The etiopathogenesis of VLS remains unknown and is likely multifactorial. Data emphasize the role of immunological factors - more than 25% of VLS cases coexist with autoimmune diseases. The purpose of the present study was to determine the correlation of the prevalence of anti-thyroid antibodies - IgG class antibodies against thyroid peroxidase and IgG class antibodies against thyroglobulin in women with vulvar lichen sclerosus, and the appropriateness of screening tests for autoimmune thyroid diseases in women with vulvar lichen sclerosus.</p><p><strong>Material and methods: </strong>Fifty women with vulvar lichen sclerosus were enrolled in the study. The control group consisted of 41 healthy women. A detailed medical history was taken with all patients, followed by laboratory determinations - anti-thyroid antibodies - IgG class antibodies against thyroid peroxidase and IgG class antibodies against thyroglobulin.</p><p><strong>Results: </strong>Antibodies to thyroid peroxidase were present in 12% of the study group with vulvar lichen sclerosus and 4.88% of the control group, and this difference was not statistically significant (p = 0.41). Anti-thyroglobulin antibodies were detected in 4% of the patients with vulvar lichen sclerosus and 4.88% of the control group, and this difference was not statistically significant either (p = 0.76).</p><p><strong>Conclusions: </strong>The study did not confirm the association of VLS with autoimmune thyroid diseases. Undoubtedly, based on the data available in the literature, further studies are needed to determine the mechanisms behind the association between vulvar lichen sclerosus and autoimmune thyroid diseases.</p>","PeriodicalId":94021,"journal":{"name":"Ginekologia polska","volume":" ","pages":"235-240"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Off-label letrozole for tubal pregnancy monotherapy is not an alternative to methotrexate: a prospective cohort study. 用于输卵管妊娠单药治疗的标签外来曲唑不能替代甲氨蝶呤:一项前瞻性队列研究。
Pub Date : 2025-01-01 Epub Date: 2024-09-17 DOI: 10.5603/gpl.100131
Iwona M Gawron, Dorota Babczyk, Robert Jach

Objectives: Inhibition of estradiol production by letrozole may interfere with physiological effects of progesterone necessary to maintain the pregnancy. Treatment of tubal pregnancy (TP) with letrozole would allow to avoid the disadvantages of methotrexate (MTX). The aim was to compare the effectiveness of letrozole with MTX in the management of TP.

Material and methods: A prospective open-label cohort study was conducted among women with TP and increasing B-human chorionic gonadotropin (B-hCG) concentrations. MTX was administered in a single dose of 100 mg intravenously, while letrozole in a dose of 5 mg orally for 10 days. Blood parameters (B-hCG, hemoglobin, creatinine, urea, transaminases, bilirubin) were tested on days 0, 4 and 7.

Results: Out of 22 eligible women, 14 received MTX and received 8 letrozole. Mean age, lesion diameter, gestation age in the MTX vs letrozole arm were: 31 vs 32 years (p = 0.3), 13.2 vs 16.3 mm (p = 0.1), 7 + 1 vs 7 + 0 weeks (p = 0.6), respectively. In case of 4 women treated with letrozole and in 2 treated with MTX (4/8, 50% vs 2/14, 14.3%, p = 0.07) the treatment was unsuccessful. There were no significant differences in blood parameters on days 0, 4 and 7 between both arms, except for the increasing urea concentration in the letrozole arm (p = 0.01).

Conclusions: Even though the results did not reach statistical significance, it is likely that a larger study sample would confirm the trend of letrozole being less effective. The results did not support the use of letrozole in the studied regimen as an alternative to MTX.

目的:来曲唑抑制雌二醇的产生可能会干扰孕酮维持妊娠所需的生理效应。来曲唑治疗输卵管妊娠(TP)可避免甲氨蝶呤(MTX)的缺点。研究旨在比较来曲唑与MTX在治疗输卵管妊娠中的有效性:在患有TP且B-人绒毛膜促性腺激素(B-hCG)浓度升高的女性中开展了一项前瞻性开放标签队列研究。MTX单剂量静脉注射100毫克,来曲唑5毫克口服,共10天。第 0、4 和 7 天检测血液参数(B-hCG、血红蛋白、肌酐、尿素、转氨酶、胆红素):在 22 名符合条件的妇女中,14 人接受了 MTX 治疗,8 人接受了来曲唑治疗。MTX治疗组和来曲唑治疗组的平均年龄、病变直径和妊娠年龄分别为31岁和32岁(P = 0.5):分别为:31 岁 vs 32 岁(P = 0.3)、13.2 mm vs 16.3 mm(P = 0.1)、7 + 1 vs 7 + 0 周(P = 0.6)。4名妇女接受来曲唑治疗,2名妇女接受MTX治疗(4/8,50% vs 2/14,14.3%,p = 0.07),治疗均未成功。除了来曲唑治疗组尿素浓度升高(p = 0.01)外,两组患者在第 0、4 和 7 天的血液参数无明显差异:尽管结果没有达到统计学意义,但更大的研究样本可能会证实来曲唑效果较差的趋势。研究结果不支持在研究方案中使用来曲唑替代MTX。
{"title":"Off-label letrozole for tubal pregnancy monotherapy is not an alternative to methotrexate: a prospective cohort study.","authors":"Iwona M Gawron, Dorota Babczyk, Robert Jach","doi":"10.5603/gpl.100131","DOIUrl":"10.5603/gpl.100131","url":null,"abstract":"<p><strong>Objectives: </strong>Inhibition of estradiol production by letrozole may interfere with physiological effects of progesterone necessary to maintain the pregnancy. Treatment of tubal pregnancy (TP) with letrozole would allow to avoid the disadvantages of methotrexate (MTX). The aim was to compare the effectiveness of letrozole with MTX in the management of TP.</p><p><strong>Material and methods: </strong>A prospective open-label cohort study was conducted among women with TP and increasing B-human chorionic gonadotropin (B-hCG) concentrations. MTX was administered in a single dose of 100 mg intravenously, while letrozole in a dose of 5 mg orally for 10 days. Blood parameters (B-hCG, hemoglobin, creatinine, urea, transaminases, bilirubin) were tested on days 0, 4 and 7.</p><p><strong>Results: </strong>Out of 22 eligible women, 14 received MTX and received 8 letrozole. Mean age, lesion diameter, gestation age in the MTX vs letrozole arm were: 31 vs 32 years (p = 0.3), 13.2 vs 16.3 mm (p = 0.1), 7 + 1 vs 7 + 0 weeks (p = 0.6), respectively. In case of 4 women treated with letrozole and in 2 treated with MTX (4/8, 50% vs 2/14, 14.3%, p = 0.07) the treatment was unsuccessful. There were no significant differences in blood parameters on days 0, 4 and 7 between both arms, except for the increasing urea concentration in the letrozole arm (p = 0.01).</p><p><strong>Conclusions: </strong>Even though the results did not reach statistical significance, it is likely that a larger study sample would confirm the trend of letrozole being less effective. The results did not support the use of letrozole in the studied regimen as an alternative to MTX.</p>","PeriodicalId":94021,"journal":{"name":"Ginekologia polska","volume":" ","pages":"51-57"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142304680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between vulvar lichen sclerosus and celiac disease in women. 女性外阴硬皮病与乳糜泻之间的关系
Pub Date : 2025-01-01 Epub Date: 2024-10-29 DOI: 10.5603/gpl.103181
Maja J Zieba-Domalik, Kacper Nizinski, Dominika Orszulak, Marta Janik, Aleksandra Fratczak, Beata Bergler-Czop, Rafal Stojko, Agnieszka Drosdzol-Cop

Objectives: Vulvar lichen sclerosus (VLS) is a chronic inflammatory condition involving mainly the genital area with an undetermined aetiology. Recent studies show that in up to 34% of cases in adult women, VLS coexists with allergies or autoimmune diseases like celiac disease (CD), among others. However, literature data relating strictly to the co-occurrence of celiac disease and Duhring's disease (DH) in patients with VLS are very limited.

Material and methods: In our study, we sought to clarify the possible relationship between vulvar lichen sclerosus in adult women and celiac disease in its cutaneous form. The aim of the study was to demonstrate the presence of celiac disease-specific antibodies in women with VLS. The control group consisted of 41 healthy women, and the study group consisted of 50 women aged 24-83 years with diagnosed vulvar lichen sclerosus who were hospitalized in the Department of Gynaecology, Obstetrics and Gynaecologic Oncology of the Bonifraters Medical Centre in Katowice.

Results: There were no significant differences in blood serum levels of CD-specific antibodies between both groups.

Conclusions: The study conducted did not confirm the association between vulvar lichen sclerosus and celiac disease or Duhring's disease. The main limitation of the research was the small size of the study and control groups. Further studies on a larger group of patients are needed. They could clarify the possible mechanisms behind the co-occurrence of these two conditions. Earlier diagnostic will help prevent the development of severe and irreversible complications.

目的:外阴硬皮病(VLS)是一种主要累及生殖器部位的慢性炎症,病因不明。最近的研究表明,在多达 34% 的成年女性病例中,外阴苔藓与过敏或自身免疫性疾病(如乳糜泻)等同时存在。然而,与 VLS 患者同时患有乳糜泻和杜林氏病(DH)严格相关的文献数据非常有限:在我们的研究中,我们试图阐明成年女性外阴硬化性苔藓与皮肤形式的乳糜泻之间可能存在的关系。研究的目的是证明患有外阴硬化症的妇女体内存在乳糜泻特异性抗体。对照组由41名健康女性组成,研究组由50名年龄在24-83岁之间、确诊患有外阴硬皮病的女性组成,她们都曾在卡托维兹博尼弗拉特斯医疗中心妇产科和妇科肿瘤部住院治疗:结果:两组患者血清中 CD 特异性抗体水平无明显差异:结论:这项研究并未证实外阴硬皮病与乳糜泻或杜林病之间存在关联。研究的主要局限性在于研究组和对照组的规模较小。需要对更大的患者群体进行进一步研究。这些研究可以阐明这两种疾病同时发生背后的可能机制。早期诊断将有助于预防严重和不可逆并发症的发生。
{"title":"Association between vulvar lichen sclerosus and celiac disease in women.","authors":"Maja J Zieba-Domalik, Kacper Nizinski, Dominika Orszulak, Marta Janik, Aleksandra Fratczak, Beata Bergler-Czop, Rafal Stojko, Agnieszka Drosdzol-Cop","doi":"10.5603/gpl.103181","DOIUrl":"10.5603/gpl.103181","url":null,"abstract":"<p><strong>Objectives: </strong>Vulvar lichen sclerosus (VLS) is a chronic inflammatory condition involving mainly the genital area with an undetermined aetiology. Recent studies show that in up to 34% of cases in adult women, VLS coexists with allergies or autoimmune diseases like celiac disease (CD), among others. However, literature data relating strictly to the co-occurrence of celiac disease and Duhring's disease (DH) in patients with VLS are very limited.</p><p><strong>Material and methods: </strong>In our study, we sought to clarify the possible relationship between vulvar lichen sclerosus in adult women and celiac disease in its cutaneous form. The aim of the study was to demonstrate the presence of celiac disease-specific antibodies in women with VLS. The control group consisted of 41 healthy women, and the study group consisted of 50 women aged 24-83 years with diagnosed vulvar lichen sclerosus who were hospitalized in the Department of Gynaecology, Obstetrics and Gynaecologic Oncology of the Bonifraters Medical Centre in Katowice.</p><p><strong>Results: </strong>There were no significant differences in blood serum levels of CD-specific antibodies between both groups.</p><p><strong>Conclusions: </strong>The study conducted did not confirm the association between vulvar lichen sclerosus and celiac disease or Duhring's disease. The main limitation of the research was the small size of the study and control groups. Further studies on a larger group of patients are needed. They could clarify the possible mechanisms behind the co-occurrence of these two conditions. Earlier diagnostic will help prevent the development of severe and irreversible complications.</p>","PeriodicalId":94021,"journal":{"name":"Ginekologia polska","volume":" ","pages":"342-347"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gynecological complications and treatment strategies in patients after hematopoietic stem cell transplantation. 造血干细胞移植后妇科并发症及治疗策略。
Pub Date : 2025-01-01 Epub Date: 2025-01-15 DOI: 10.5603/gpl.102573
Kinga Wdowiarz, Malgorzata Reinholz-Jaskolska, Malgorzata Radowicka, Miroslaw Wielgos, Bronislawa Pietrzak

In women after hematopoietic stem cell transplantation (HSCT), complications associated with the original disease and therapies used both before and after transplantation often occur, which significantly affects their quality of life. The most common gynaecological complications include secondary cancers, premature ovarian insufficiency (POI), infertility and chronic graft-versus-host disease (cGVHD). Cervical cancer is the most common secondary genital cancer in patients after HSCT. Regular screening and vaccination against HPV (Human Papillomavirus) can significantly reduce the risk for its occurrence. The specific complication after allogeneic hematopoietic stem cell transplantation is graft-versus-host disease (GVHD), the genital form of which can lead to labial and vaginal adhesions, significantly reducing the women's quality of life. The basis of treatment is local steroid therapy and immunosuppression. A consequence of chemotherapy and radiation therapy may be damage to the gonads leading to premature ovarian insufficiency and the onset of menopause symptoms. The basis of treatment is systemic hormone therapy used until middle age when natural menopause is reached. Women after HSCT who are of reproductive age also suffer from infertility. An important role of the doctor is to educate patients about the risk for infertility and to suggest appropriate methods of preserving fertility before starting treatment. The recommended procedure for fertility preservation is cryopreservation of embryos or oocytes. The freezing and retransplantation of ovarian tissue is becoming an increasingly popular method of fertility protection. Preventive examinations and early detection and treatment of gynaecological complications significantly improve the comfort of life and health of women after HSCT.

在接受造血干细胞移植(HSCT)的女性中,经常发生与原疾病和移植前后使用的治疗相关的并发症,这显著影响了她们的生活质量。最常见的妇科并发症包括继发性癌症、卵巢功能不全(POI)、不孕症和慢性移植物抗宿主病(cGVHD)。宫颈癌是HSCT后患者中最常见的继发性生殖器癌。定期筛查和接种HPV(人乳头瘤病毒)疫苗可显著降低其发生的风险。同种异体造血干细胞移植后的特殊并发症是移植物抗宿主病(GVHD),其生殖器形式可导致阴唇和阴道粘连,显著降低女性的生活质量。治疗的基础是局部类固醇治疗和免疫抑制。化疗和放疗的后果可能是对性腺的损害,导致卵巢功能不全和更年期症状的出现。治疗的基础是使用全身性激素治疗,直到中年达到自然更年期。经HSCT的育龄妇女也患有不孕症。医生的一个重要作用是教育患者不孕的风险,并在开始治疗前建议适当的保留生育能力的方法。保存生育能力的推荐方法是冷冻保存胚胎或卵母细胞。卵巢组织的冷冻和再移植已成为一种日益流行的生育保护方法。预防性检查和妇科并发症的早期发现和治疗显著改善了移植后妇女的生活舒适度和健康状况。
{"title":"Gynecological complications and treatment strategies in patients after hematopoietic stem cell transplantation.","authors":"Kinga Wdowiarz, Malgorzata Reinholz-Jaskolska, Malgorzata Radowicka, Miroslaw Wielgos, Bronislawa Pietrzak","doi":"10.5603/gpl.102573","DOIUrl":"10.5603/gpl.102573","url":null,"abstract":"<p><p>In women after hematopoietic stem cell transplantation (HSCT), complications associated with the original disease and therapies used both before and after transplantation often occur, which significantly affects their quality of life. The most common gynaecological complications include secondary cancers, premature ovarian insufficiency (POI), infertility and chronic graft-versus-host disease (cGVHD). Cervical cancer is the most common secondary genital cancer in patients after HSCT. Regular screening and vaccination against HPV (Human Papillomavirus) can significantly reduce the risk for its occurrence. The specific complication after allogeneic hematopoietic stem cell transplantation is graft-versus-host disease (GVHD), the genital form of which can lead to labial and vaginal adhesions, significantly reducing the women's quality of life. The basis of treatment is local steroid therapy and immunosuppression. A consequence of chemotherapy and radiation therapy may be damage to the gonads leading to premature ovarian insufficiency and the onset of menopause symptoms. The basis of treatment is systemic hormone therapy used until middle age when natural menopause is reached. Women after HSCT who are of reproductive age also suffer from infertility. An important role of the doctor is to educate patients about the risk for infertility and to suggest appropriate methods of preserving fertility before starting treatment. The recommended procedure for fertility preservation is cryopreservation of embryos or oocytes. The freezing and retransplantation of ovarian tissue is becoming an increasingly popular method of fertility protection. Preventive examinations and early detection and treatment of gynaecological complications significantly improve the comfort of life and health of women after HSCT.</p>","PeriodicalId":94021,"journal":{"name":"Ginekologia polska","volume":" ","pages":"399-404"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142985828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current approach to the use of transvaginal mesh systems in pelvic organ prolapse. 目前的方法使用经阴道网系统盆腔器官脱垂。
Pub Date : 2025-01-01 Epub Date: 2025-03-27 DOI: 10.5603/gpl.101432
Monika Pycek, Justyna M Zarzecka, Wojciech Majkusiak, Ewa M Barcz, Aneta Zwierzchowska

Pelvic organ prolapse (POP) involves the descent of vaginal walls, uterus, or vaginal apex. Traditional native tissue repair techniques, while low in complications, exhibit significant relapse rates. To enhance durability of surgical repair, synthetic mesh systems were adopted. However, early generations faced complications such as vaginal mesh exposure and dyspareunia, leading to critical reevaluation and regulatory actions. The Food and Drug Administration issued first warning in 2008 and reclassified mesh as high-risk in 2016, banning it for transvaginal anterior compartment prolapse in 2019. European and Canadian regulations similarly increased scrutiny, with prominent professional organizations and regulatory bodies endorsing limited use and thorough counseling. Subsequent innovations introduced lighter mesh systems with sacrospinous ligament fixation, which improved anatomical outcomes and reduced adverse effects. Recent studies on these systems demonstrate promising success rates, with notable reductions in prolapse recurrence and improved quality of life. Given these developments, current perspectives advocate for selective use of advanced mesh systems in POP surgery, emphasizing rigorous patient selection, informed consent, and meticulous surgical technique. This careful approach, as opposed to a categorical ban, aims to balance the therapeutic benefits with potential risks, ensuring optimized patient outcomes in POP management.

盆腔器官脱垂(POP)涉及阴道壁、子宫或阴道顶点的下降。传统的组织修复技术虽然并发症少,但复发率高。为了提高手术修复的耐久性,采用了合成补片系统。然而,早期几代人面临诸如阴道网片暴露和性交困难等并发症,导致关键的重新评估和监管行动。美国食品和药物管理局于2008年发布了第一个警告,并于2016年将网状物重新归类为高风险,并于2019年禁止其用于经阴道前室脱垂。欧洲和加拿大的法规同样加强了审查,著名的专业组织和监管机构支持有限的使用和彻底的咨询。随后的创新引入了更轻的网状系统与骶棘韧带固定,改善了解剖结果,减少了不良反应。最近对这些系统的研究表明,有希望的成功率,显著减少脱垂复发和提高生活质量。鉴于这些发展,目前的观点主张在POP手术中选择性地使用先进的网状系统,强调严格的患者选择,知情同意和细致的手术技术。这种谨慎的方法,而不是完全禁止,旨在平衡治疗益处和潜在风险,确保在POP管理中优化患者结果。
{"title":"Current approach to the use of transvaginal mesh systems in pelvic organ prolapse.","authors":"Monika Pycek, Justyna M Zarzecka, Wojciech Majkusiak, Ewa M Barcz, Aneta Zwierzchowska","doi":"10.5603/gpl.101432","DOIUrl":"10.5603/gpl.101432","url":null,"abstract":"<p><p>Pelvic organ prolapse (POP) involves the descent of vaginal walls, uterus, or vaginal apex. Traditional native tissue repair techniques, while low in complications, exhibit significant relapse rates. To enhance durability of surgical repair, synthetic mesh systems were adopted. However, early generations faced complications such as vaginal mesh exposure and dyspareunia, leading to critical reevaluation and regulatory actions. The Food and Drug Administration issued first warning in 2008 and reclassified mesh as high-risk in 2016, banning it for transvaginal anterior compartment prolapse in 2019. European and Canadian regulations similarly increased scrutiny, with prominent professional organizations and regulatory bodies endorsing limited use and thorough counseling. Subsequent innovations introduced lighter mesh systems with sacrospinous ligament fixation, which improved anatomical outcomes and reduced adverse effects. Recent studies on these systems demonstrate promising success rates, with notable reductions in prolapse recurrence and improved quality of life. Given these developments, current perspectives advocate for selective use of advanced mesh systems in POP surgery, emphasizing rigorous patient selection, informed consent, and meticulous surgical technique. This careful approach, as opposed to a categorical ban, aims to balance the therapeutic benefits with potential risks, ensuring optimized patient outcomes in POP management.</p>","PeriodicalId":94021,"journal":{"name":"Ginekologia polska","volume":" ","pages":"414-419"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143723004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sexual education around the world: in Australia and Oceania and Europe. 世界各地的性教育:在澳大利亚、大洋洲和欧洲。
Pub Date : 2025-01-01 Epub Date: 2025-01-15 DOI: 10.5603/gpl.103664
Anna Botor, Karolina Bator, Szymon Stojko, Rafal Stojko, Agnieszka Drosdzol-Cop

Sexual education is a vital process of teaching and learning about various aspects of human sexuality, including physical, emotional, social, and cultural dimensions. Its primary goal is to equip individuals, especially adolescents, with the necessary knowledge, skills, and values to make informed, responsible, and safe decisions regarding their sexual and reproductive lives. This article examines sexual education programs in Australia, Oceania, and Europe, addressing the current state, the unique challenges, and recommendations for enhancing these programs to meet the needs of modern society.

性教育是教授和学习人类性的各个方面的重要过程,包括身体、情感、社会和文化方面。其主要目标是使个人,特别是青少年具备必要的知识、技能和价值观,以便就其性生活和生殖生活作出知情、负责任和安全的决定。本文考察了澳大利亚、大洋洲和欧洲的性教育项目,阐述了当前的状态、独特的挑战,并提出了加强这些项目以满足现代社会需求的建议。
{"title":"Sexual education around the world: in Australia and Oceania and Europe.","authors":"Anna Botor, Karolina Bator, Szymon Stojko, Rafal Stojko, Agnieszka Drosdzol-Cop","doi":"10.5603/gpl.103664","DOIUrl":"10.5603/gpl.103664","url":null,"abstract":"<p><p>Sexual education is a vital process of teaching and learning about various aspects of human sexuality, including physical, emotional, social, and cultural dimensions. Its primary goal is to equip individuals, especially adolescents, with the necessary knowledge, skills, and values to make informed, responsible, and safe decisions regarding their sexual and reproductive lives. This article examines sexual education programs in Australia, Oceania, and Europe, addressing the current state, the unique challenges, and recommendations for enhancing these programs to meet the needs of modern society.</p>","PeriodicalId":94021,"journal":{"name":"Ginekologia polska","volume":" ","pages":"393-398"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142985843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The prevalence of Group B Streptococcus rectovaginal colonization and antimicrobial susceptibility pattern in Turkish and Syrian pregnant women. 土耳其和叙利亚孕妇B群链球菌直肠阴道定植的流行和抗菌药物敏感性模式
Pub Date : 2025-01-01 Epub Date: 2025-03-27 DOI: 10.5603/gpl.102721
Emine Kirtis, Burak Karadag, Aysel Uysal, Yeşim Çekin, Gul Alkan Bulbul

Objectives: Colonization with Group B Streptococcus (GBS) during pregnancy can lead to invasive GBS disease (iGBS) in neonates, including meningitis, pneumonia or sepsis, which carries a high mortality risk. American College of Obstetricians and Gynecologists (ACOG) recommends universal GBS screening for all pregnant individuals between 36 0/7 and 37 6/7 weeks of gestation. However, due to the insufficient population-based studies on universal screening and GBS colonization rates in late periods of pregnancy in Türkiye, we aimed to evaluate the prevalence of GBS and its antibiotic resistance to enhance awareness regarding GBS screening and prophylaxis during pregnancy and promote the use of appropriate antibiotics.

Material and methods: This prospective, single-center study was conducted between May 2017 and December 2017 on 518 pregnant women (363 Turkish and 155 Syrian). Vaginal and rectal samples were collected and cultured in Todd-Hewitt broth. Standard microbiological protocols were used to assess GBS colonization and antibiotic susceptibility.

Results: In the study, we found that 10.6% (n = 55) of pregnant women were colonized with GBS asymptomatically. Group B Streptococcus colonization rates did not differ significantly between Turkish patients (11%, n = 40) and Syrian patients (9.7%, n = 15) (p = 0.756, p > 0.05). All patients colonized with GBS were penicillin-sensitive. However, resistance to at least one non-penicillin antibiotic was observed in 42.5% (n = 17) of Turkish patients and 60% (n = 9) of Syrian patients. Although not statistically significant (p > 0.05), Syrian patients exhibited relatively higher rates of antibiotic resistance, especially to erythrosine and clindamycin.

Conclusions: In our country, implementing universal screening for asymptomatic GBS in pregnant women, as recommended by the Centers for Disease Control and Prevention (CDC), would be more beneficial than a risk-based screening approach. Given the increased resistance patterns observed in antibiogram results, GBS prophylaxis at delivery, especially in patients with penicillin allergies, should be planned based on antibiotic susceptibility testing.

目的:妊娠期间B群链球菌(GBS)定植可导致新生儿侵袭性GBS疾病(iGBS),包括脑膜炎、肺炎或败血症,这些疾病具有很高的死亡风险。美国妇产科医师学会(ACOG)建议对妊娠36周/7至37周/7之间的所有孕妇进行GBS筛查。然而,由于基于人群的普遍筛查和妊娠后期GBS定植率的研究不足,我们旨在评估GBS的患病率及其抗生素耐药性,以提高人们对妊娠期GBS筛查和预防的认识,并促进适当抗生素的使用。材料和方法:该前瞻性单中心研究于2017年5月至2017年12月期间对518名孕妇(363名土耳其人和155名叙利亚人)进行。收集阴道和直肠样本,在Todd-Hewitt肉汤中培养。采用标准微生物学方案评估GBS定植和抗生素敏感性。结果:在研究中,我们发现10.6% (n = 55)的孕妇无症状地定植了GBS。土耳其患者(11%,n = 40)和叙利亚患者(9.7%,n = 15)的B组链球菌定植率差异无统计学意义(p = 0.756, p = 0.05)。所有感染GBS的患者均对青霉素敏感。然而,42.5% (n = 17)的土耳其患者和60% (n = 9)的叙利亚患者对至少一种非青霉素类抗生素耐药。虽然没有统计学意义(p < 0.05),但叙利亚患者表现出相对较高的抗生素耐药率,特别是对红霉素和克林霉素。结论:在我国,按照疾病控制和预防中心(CDC)的建议,对孕妇实施无症状GBS的普遍筛查,将比基于风险的筛查方法更有益。鉴于抗生素谱结果中观察到的耐药模式增加,分娩时的GBS预防,特别是青霉素过敏患者,应根据抗生素敏感性试验来计划。
{"title":"The prevalence of Group B Streptococcus rectovaginal colonization and antimicrobial susceptibility pattern in Turkish and Syrian pregnant women.","authors":"Emine Kirtis, Burak Karadag, Aysel Uysal, Yeşim Çekin, Gul Alkan Bulbul","doi":"10.5603/gpl.102721","DOIUrl":"10.5603/gpl.102721","url":null,"abstract":"<p><strong>Objectives: </strong>Colonization with Group B Streptococcus (GBS) during pregnancy can lead to invasive GBS disease (iGBS) in neonates, including meningitis, pneumonia or sepsis, which carries a high mortality risk. American College of Obstetricians and Gynecologists (ACOG) recommends universal GBS screening for all pregnant individuals between 36 0/7 and 37 6/7 weeks of gestation. However, due to the insufficient population-based studies on universal screening and GBS colonization rates in late periods of pregnancy in Türkiye, we aimed to evaluate the prevalence of GBS and its antibiotic resistance to enhance awareness regarding GBS screening and prophylaxis during pregnancy and promote the use of appropriate antibiotics.</p><p><strong>Material and methods: </strong>This prospective, single-center study was conducted between May 2017 and December 2017 on 518 pregnant women (363 Turkish and 155 Syrian). Vaginal and rectal samples were collected and cultured in Todd-Hewitt broth. Standard microbiological protocols were used to assess GBS colonization and antibiotic susceptibility.</p><p><strong>Results: </strong>In the study, we found that 10.6% (n = 55) of pregnant women were colonized with GBS asymptomatically. Group B Streptococcus colonization rates did not differ significantly between Turkish patients (11%, n = 40) and Syrian patients (9.7%, n = 15) (p = 0.756, p > 0.05). All patients colonized with GBS were penicillin-sensitive. However, resistance to at least one non-penicillin antibiotic was observed in 42.5% (n = 17) of Turkish patients and 60% (n = 9) of Syrian patients. Although not statistically significant (p > 0.05), Syrian patients exhibited relatively higher rates of antibiotic resistance, especially to erythrosine and clindamycin.</p><p><strong>Conclusions: </strong>In our country, implementing universal screening for asymptomatic GBS in pregnant women, as recommended by the Centers for Disease Control and Prevention (CDC), would be more beneficial than a risk-based screening approach. Given the increased resistance patterns observed in antibiogram results, GBS prophylaxis at delivery, especially in patients with penicillin allergies, should be planned based on antibiotic susceptibility testing.</p>","PeriodicalId":94021,"journal":{"name":"Ginekologia polska","volume":" ","pages":"490-495"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143722961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NMR-based serum metabolomics in patients with low-differentiated serous ovarian cancer. 基于核磁共振的低分化浆液性卵巢癌患者血清代谢组学研究。
Pub Date : 2025-01-01 Epub Date: 2025-04-25 DOI: 10.5603/gpl.101741
Mateusz M Klimek, Agnieszka Skorupa, Mateusz Ciszek, Tomasz Cichon, Bartosz Cichon, Lukasz Boguszewicz, Andrzej Witek, Maria Sokol

Objectives: In this pilot study the proton Nuclear Magnetic Resonance (¹H NMR)-based metabolomics was applied to explore the serum metabolomes of the patients with high-grade serous ovarian carcinoma (HGSOC) and the patients with benign gynaecological disease and to identify the characteristic biomarkers.

Material and methods: We analyzed serum samples from 17 HGSOC patients and 14 control patients with benign gynecological conditions. Serum metabolites were profiled using 1H NMR spectroscopy, and multivariate data analyses, including Orthogonal Partial Least Squares Discriminant Analysis (OPLS-DA), were performed to identify discriminating metabolites.

Results: The multivariate analysis revealed the lower levels of the lipid compounds, choline, branched-chain amino acids, 3-hydroxybutyrate (3HB), acetoacetate, and the higher level of lactate in the sera of the HGSOC patients compared to the control group.

Conclusions: NMR-based metabolomic analysis can serve as a supporting method for the detection of ovarian cancer and may be useful as an adjunct to molecular diagnostics.

目的:应用质子核磁共振(¹H NMR)为基础的代谢组学方法,探讨高级别浆液性卵巢癌(HGSOC)患者和妇科良性疾病患者的血清代谢组学特征,并鉴定其特征生物标志物。材料和方法:我们分析了17例HGSOC患者和14例良性妇科疾病对照患者的血清样本。使用1H NMR谱分析血清代谢物,并进行多变量数据分析,包括正交偏最小二乘判别分析(OPLS-DA),以确定判别代谢物。结果:多因素分析显示,与对照组相比,HGSOC患者血清中脂类化合物、胆碱、支链氨基酸、3-羟基丁酸(3HB)、乙酰乙酸水平较低,乳酸水平较高。结论:基于核磁共振的代谢组学分析可作为卵巢癌检测的辅助方法,并可作为分子诊断的辅助手段。
{"title":"NMR-based serum metabolomics in patients with low-differentiated serous ovarian cancer.","authors":"Mateusz M Klimek, Agnieszka Skorupa, Mateusz Ciszek, Tomasz Cichon, Bartosz Cichon, Lukasz Boguszewicz, Andrzej Witek, Maria Sokol","doi":"10.5603/gpl.101741","DOIUrl":"10.5603/gpl.101741","url":null,"abstract":"<p><strong>Objectives: </strong>In this pilot study the proton Nuclear Magnetic Resonance (¹H NMR)-based metabolomics was applied to explore the serum metabolomes of the patients with high-grade serous ovarian carcinoma (HGSOC) and the patients with benign gynaecological disease and to identify the characteristic biomarkers.</p><p><strong>Material and methods: </strong>We analyzed serum samples from 17 HGSOC patients and 14 control patients with benign gynecological conditions. Serum metabolites were profiled using 1H NMR spectroscopy, and multivariate data analyses, including Orthogonal Partial Least Squares Discriminant Analysis (OPLS-DA), were performed to identify discriminating metabolites.</p><p><strong>Results: </strong>The multivariate analysis revealed the lower levels of the lipid compounds, choline, branched-chain amino acids, 3-hydroxybutyrate (3HB), acetoacetate, and the higher level of lactate in the sera of the HGSOC patients compared to the control group.</p><p><strong>Conclusions: </strong>NMR-based metabolomic analysis can serve as a supporting method for the detection of ovarian cancer and may be useful as an adjunct to molecular diagnostics.</p>","PeriodicalId":94021,"journal":{"name":"Ginekologia polska","volume":" ","pages":"437-445"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144029155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Professional perspectives on external cephalic version: survey results among Polish midwives and obstetricians. 专业视角的外头位版本:波兰助产士和产科医生的调查结果。
IF 1 Pub Date : 2025-01-01 Epub Date: 2025-03-12 DOI: 10.5603/gpl.104146
Maisa Manasar-Dyrbus, Cecylia Jendyk, Anna Janik, Agnieszka Drosdzol-Cop, Rafal Stojko, Jakub Staniczek

Objectives: The purpose of this study was to assess and compare the knowledge, attitudes, and practices of Polish midwives and obstetricians concerning external cephalic version (ECV), with particular attention to how professional qualifications, experience, and the reference level of the healthcare facility influenced these factors across both groups.

Material and methods: An author-created, 22-question online survey was distributed separately to midwives and obstetricians, with each group receiving a questionnaire customized to assess their specific knowledge of ECV, professional experience, and attitudes toward the procedure.

Results: The study included 839 participants: 378 midwives and 461 physicians. Knowledge and experience with ECV varied significantly based on work experience and the reference level of the workplace. When comparing the results between midwives and obstetricians, the median (Q1-Q3) score for correct answers on ECV was highest among obstetrics and gynecology residents (5, 3-6), while the lowest scores were seen among midwives with bachelor's degrees (2, 1-4).

Conclusions: The study identified significant considerable knowledge gaps regarding ECV, particularly among midwives. Educational initiatives targeting both midwives and obstetricians are recommended to encourage the greater use of ECV and potentially reduce the rates of elective cesarean sections in cases of non-cephalic fetal presentations.

目的:本研究的目的是评估和比较波兰助产士和产科医生关于头外版本(ECV)的知识、态度和做法,特别关注专业资格、经验和医疗机构的参考水平如何影响两组的这些因素。材料和方法:作者创建了一份包含22个问题的在线调查,分别分发给助产士和产科医生,每组都收到一份定制的问卷,以评估他们对ECV的具体知识、专业经验和对手术的态度。结果:该研究包括839名参与者:378名助产士和461名医生。ECV的知识和经验因工作经验和工作场所的参考水平而有显著差异。当比较助产士和产科医生之间的结果时,在产科和妇科住院医生中,ECV正确答案的中位数(Q1-Q3)得分最高(5,3 -6),而在拥有学士学位的助产士中得分最低(2,1 -4)。结论:该研究确定了关于ECV的相当大的知识差距,特别是助产士。建议针对助产士和产科医生开展教育活动,以鼓励更多地使用ECV,并可能降低非头位胎儿出现的选择性剖宫产率。
{"title":"Professional perspectives on external cephalic version: survey results among Polish midwives and obstetricians.","authors":"Maisa Manasar-Dyrbus, Cecylia Jendyk, Anna Janik, Agnieszka Drosdzol-Cop, Rafal Stojko, Jakub Staniczek","doi":"10.5603/gpl.104146","DOIUrl":"10.5603/gpl.104146","url":null,"abstract":"<p><strong>Objectives: </strong>The purpose of this study was to assess and compare the knowledge, attitudes, and practices of Polish midwives and obstetricians concerning external cephalic version (ECV), with particular attention to how professional qualifications, experience, and the reference level of the healthcare facility influenced these factors across both groups.</p><p><strong>Material and methods: </strong>An author-created, 22-question online survey was distributed separately to midwives and obstetricians, with each group receiving a questionnaire customized to assess their specific knowledge of ECV, professional experience, and attitudes toward the procedure.</p><p><strong>Results: </strong>The study included 839 participants: 378 midwives and 461 physicians. Knowledge and experience with ECV varied significantly based on work experience and the reference level of the workplace. When comparing the results between midwives and obstetricians, the median (Q1-Q3) score for correct answers on ECV was highest among obstetrics and gynecology residents (5, 3-6), while the lowest scores were seen among midwives with bachelor's degrees (2, 1-4).</p><p><strong>Conclusions: </strong>The study identified significant considerable knowledge gaps regarding ECV, particularly among midwives. Educational initiatives targeting both midwives and obstetricians are recommended to encourage the greater use of ECV and potentially reduce the rates of elective cesarean sections in cases of non-cephalic fetal presentations.</p>","PeriodicalId":94021,"journal":{"name":"Ginekologia polska","volume":" ","pages":"561-569"},"PeriodicalIF":1.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143607566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Ginekologia polska
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1